ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
PDF (2.2M)
Journal: 1993/February - Clinical and Experimental Immunology
ISSN: 0009-9104
PUBMED: 8419069
Abstract:
The past decade has seen an explosion of data on the new group of autoantibodies known collectively as ANCA (anti-neutrophil cytoplasmic antibodies). ANCA are specific for granule proteins of granulocytes and monocytes and induce distinct fluorescence patterns, e.g. the cytoplasmic (classic) cANCA and the perinuclear pANCA. cANCA is induced by antibodies directed against Proteinase 3 (PR3; PR3-ANCA) in about 90% of all ANCA-positive sera, and pANCA is induced by antibodies against myeloperoxidase (MPO; MPO-ANCA) in about 40%. A further staining pattern, which does not have a clear cut association with a distinct granule protein, is sometimes seen in chronic inflammatory bowel diseases. PR3-ANCA are serological markers for Wegener's granulomatosis (WG) and MPO-ANCA are associated with certain subtypes of primary vasculitides. Evidence exists that both the autoantigen and ANCA participate in the pathogenesis of at least the group of 'ANCA-associated vasculitides'.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(62)
References
(96)
Diseases
(4)
Conditions
(1)
Chemicals
(3)
Organisms
(2)
Anatomy
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Clin Exp Immunol 91(1): 1-12
PMID: 8419069

ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Abstract

The past decade has seen an explosion of data on the new group of autoantibodies known collectively as ANCA (anti-neutrophil cytoplasmic antibodies). ANCA are specific for granule proteins of granulocytes and monocytes and induce distinct fluorescence patterns, e.g. the cytoplasmic (classic) cANCA and the perinuclear pANCA. cANCA is induced by antibodies directed against Proteinase 3 (PR3; PR3-ANCA) in about 90% of all ANCA-positive sera, and pANCA is induced by antibodies against myeloperoxidase (MPO; MPO-ANCA) in about 40%. A further staining pattern, which does not have a clear cut association with a distinct granule protein, is sometimes seen in chronic inflammatory bowel diseases. PR3-ANCA are serological markers for Wegener's granulomatosis (WG) and MPO-ANCA are associated with certain subtypes of primary vasculitides. Evidence exists that both the autoantigen and ANCA participate in the pathogenesis of at least the group of 'ANCA-associated vasculitides'.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 1
1
icon of scanned page 2
2
icon of scanned page 3
3
icon of scanned page 4
4
icon of scanned page 5
5
icon of scanned page 6
6
icon of scanned page 7
7
icon of scanned page 8
8
icon of scanned page 9
9
icon of scanned page 10
10
icon of scanned page 11
11
icon of scanned page 12
12

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed) 285(6342):606–606.[PMC free article] [PubMed] [Google Scholar]
  • Hall JB, Wadham BM, Wood CJ, Ashton V, Adam WR. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. Aust N Z J Med. 1984 Jun;14(3):277–278. [PubMed] [Google Scholar]
  • van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. [PubMed] [Google Scholar]
  • Gross WL, Lüdemann G, Kiefer G, Lehmann H. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet. 1986 Apr 5;1(8484):806–806. [PubMed] [Google Scholar]
  • Parlevliet KJ, Henzen-Logmans SC, Oe PL, Bronsveld W, Balm AJ, Donker AJ. Antibodies to components of neutrophil cytoplasm: a new diagnostic tool in patients with Wegener's granulomatosis and systemic vasculitis. Q J Med. 1988 Jan;66(249):55–63. [PubMed] [Google Scholar]
  • Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988 Jun 23;318(25):1651–1657. [PubMed] [Google Scholar]
  • Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis. 1990 Jun;15(6):517–529. [PubMed] [Google Scholar]
  • Ewert BH, Jennette JC, Falk RJ. The pathogenic role of antineutrophil cytoplasmic autoantibodies. Am J Kidney Dis. 1991 Aug;18(2):188–195. [PubMed] [Google Scholar]
  • Gross WL, Csernok E, Schmitt WH. Antineutrophil cytoplasmic autoantibodies: immunobiological aspects. Klin Wochenschr. 1991 Sep 3;69(13):558–566. [PubMed] [Google Scholar]
  • Kallenberg CG, Tervaert JW, van der Woude FJ, Goldschmeding R, von dem Borne AE, Weening JJ. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol Today. 1991 Feb;12(2):61–64. [PubMed] [Google Scholar]
  • Lüdemann J, Utecht B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med. 1990 Jan 1;171(1):357–362.[PMC free article] [PubMed] [Google Scholar]
  • Rump JA, Schölmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, Lüdemann J, Gross WL, Peter HH. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology. 1990 Nov;181(4-5):406–413. [PubMed] [Google Scholar]
  • Rasmussen N, Wiik A, Høier-Madsen M, Borregaard N, van der Woude F. Anti-neutrophil cytoplasm antibodies 1988. Lancet. 1988 Mar 26;1(8587):706–707. [PubMed] [Google Scholar]
  • Lüdemann J, Utecht B, Gross WL. Detection and quantitation of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis by ELISA using affinity-purified antigen. J Immunol Methods. 1988 Nov 10;114(1-2):167–174. [PubMed] [Google Scholar]
  • Lesavre P. Antineutrophil cytoplasmic autoantibodies antigen specificity. Am J Kidney Dis. 1991 Aug;18(2):159–163. [PubMed] [Google Scholar]
  • Lockwood CM, Bakes D, Jones S, Whitaker KB, Moss DW, Savage CO. Association of alkaline phosphatase with an autoantigen recognised by circulating anti-neutrophil antibodies in systemic vasculitis. Lancet. 1987 Mar 28;1(8535):716–720. [PubMed] [Google Scholar]
  • Wieslander J. How are antineutrophil cytoplasmic autoantibodies detected? Am J Kidney Dis. 1991 Aug;18(2):154–158. [PubMed] [Google Scholar]
  • Bini P, Gabay JE, Teitel A, Melchior M, Zhou JL, Elkon KB. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J Immunol. 1992 Aug 15;149(4):1409–1415. [PubMed] [Google Scholar]
  • Boudes P. Acquired chronic granulomatous disease and Wegener's granulomatosis. Br J Rheumatol. 1989 Aug;28(4):361–362. [PubMed] [Google Scholar]
  • Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. [PubMed] [Google Scholar]
  • Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW, Jr, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990 Aug;33(8):1101–1107. [PubMed] [Google Scholar]
  • Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond. 1990 Oct;24(4):284–288.[PMC free article] [PubMed] [Google Scholar]
  • Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 1989 Jul 1;111(1):28–40. [PubMed] [Google Scholar]
  • Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, Meijer S, van der Giessen M, van der Hem GK, The TH, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med. 1989 Nov;149(11):2461–2465. [PubMed] [Google Scholar]
  • Tervaert JW, Huitema MG, Hené RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CG. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet. 1990 Sep 22;336(8717):709–711. [PubMed] [Google Scholar]
  • Savage CO, Lockwood CM. Antineutrophil antibodies in vasculitis. Adv Nephrol Necker Hosp. 1990;19:225–236. [PubMed] [Google Scholar]
  • Egner W, Chapel HM. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol. 1990 Nov;82(2):244–249.[PMC free article] [PubMed] [Google Scholar]
  • Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992 Mar 15;116(6):488–498. [PubMed] [Google Scholar]
  • Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med. 1990 Nov 1;113(9):656–663. [PubMed] [Google Scholar]
  • Bleil L, Manger B, Winkler TH, Herrman M, Burmester GR, Krapf FE, Kalden JR. The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis. J Rheumatol. 1991 Aug;18(8):1199–1206. [PubMed] [Google Scholar]
  • Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, Kallenberg CG. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med. 1991 Jul;91(1):59–66. [PubMed] [Google Scholar]
  • Davenport A. "False positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol. 1992 Mar;37(3):124–130. [PubMed] [Google Scholar]
  • Klaassen RJ, Goldschmeding R, Dolman KM, Vlekke AB, Weigel HM, Eeftinck Schattenkerk JK, Mulder JW, Westedt ML, von dem Borne AE. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol. 1992 Jan;87(1):24–30.[PMC free article] [PubMed] [Google Scholar]
  • Koderisch J, Andrassy K, Rasmussen N, Hartmann M, Tilgen W. "False-positive" anti-neutrophil cytoplasmic antibodies in HIV infection. Lancet. 1990 May 19;335(8699):1227–1228. [PubMed] [Google Scholar]
  • Efthimiou J, Spickett G, Lane D, Thompson A. Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet. 1991 Apr 27;337(8748):1037–1038. [PubMed] [Google Scholar]
  • Esnault VL, Jayne DR, Keogan MT, Brownlee AA, Testa A, Lecarrer D, Brown DL, Lockwood CM. Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies. J Clin Lab Immunol. 1990 Aug;32(4):153–159. [PubMed] [Google Scholar]
  • Finnegan MJ, Hinchcliffe J, Russell-Jones D, Neill S, Sheffield E, Jayne D, Wise A, Hodson ME. Vasculitis complicating cystic fibrosis. Q J Med. 1989 Jul;72(267):609–621. [PubMed] [Google Scholar]
  • Travis WD, Pittaluga S, Lipschik GY, Ognibene FP, Suffredini AF, Masur H, Feuerstein I, Kovacs J, Pass HI, Condron KS, et al. Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am J Surg Pathol. 1990 Jul;14(7):615–625. [PubMed] [Google Scholar]
  • Calabrese LH. Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am. 1991 Feb;17(1):131–147. [PubMed] [Google Scholar]
  • Sánchez-Guerrero J, Gutiérrez-Ureña S, Vidaller A, Reyes E, Iglesias A, Alarcón-Segovia D. Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J Rheumatol. 1990 Nov;17(11):1458–1462. [PubMed] [Google Scholar]
  • Kalina PH, Garrity JA, Herman DC, DeRemee RA, Specks U. Role of testing for anticytoplasmic autoantibodies in the differential diagnosis of scleritis and orbital pseudotumor. Mayo Clin Proc. 1990 Aug;65(8):1110–1117. [PubMed] [Google Scholar]
  • Ross CN, Tam FW, Winter RJ, Pusey CD, Rees AJ. Anti-neutrophil cytoplasmic antibodies and subglottic stenosis. Lancet. 1990 May 19;335(8699):1231–1232. [PubMed] [Google Scholar]
  • Ayliffe W, Haeney M, Roberts SC, Lavin M. Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy. Lancet. 1992 Feb 29;339(8792):558–559. [PubMed] [Google Scholar]
  • Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg CG, von dem Borne AE. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest. 1989 Nov;84(5):1577–1587.[PMC free article] [PubMed] [Google Scholar]
  • Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR. Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest. 1988 Dec;82(6):1963–1973.[PMC free article] [PubMed] [Google Scholar]
  • Wilde CG, Snable JL, Griffith JE, Scott RW. Characterization of two azurphil granule proteases with active-site homology to neutrophil elastase. J Biol Chem. 1990 Feb 5;265(4):2038–2041. [PubMed] [Google Scholar]
  • Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood. 1989 Nov 1;74(6):1888–1893. [PubMed] [Google Scholar]
  • Mayet WJ, Hermann E, Csernok E, Knuth A, Poralla T, Gross WL, Meyer zum Büschenfelde KH. A human renal cancer line as a new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegener's granulomatosis. J Immunol Methods. 1991 Sep 20;143(1):57–68. [PubMed] [Google Scholar]
  • Campanelli D, Melchior M, Fu Y, Nakata M, Shuman H, Nathan C, Gabay JE. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med. 1990 Dec 1;172(6):1709–1715.[PMC free article] [PubMed] [Google Scholar]
  • Gabay JE, Scott RW, Campanelli D, Griffith J, Wilde C, Marra MN, Seeger M, Nathan CF. Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5610–5614.[PMC free article] [PubMed] [Google Scholar]
  • DeRemee RA. The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision? Arthritis Rheum. 1988 Aug;31(8):1068–1074. [PubMed] [Google Scholar]
  • Steppat D, Gross WL. Stage-adapted treatment of Wegener's granulomatosis. First results of a prospective study. Klin Wochenschr. 1989 Jul 3;67(13):666–671. [PubMed] [Google Scholar]
  • Bories D, Raynal MC, Solomon DH, Darzynkiewicz Z, Cayre YE. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell. 1989 Dec 22;59(6):959–968. [PubMed] [Google Scholar]
  • Labbaye C, Musette P, Cayre YE. Wegener autoantigen and myeloblastin are encoded by a single mRNA. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9253–9256.[PMC free article] [PubMed] [Google Scholar]
  • Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem. 1991 May 25;266(15):9540–9548. [PubMed] [Google Scholar]
  • Wardle EN. Cells and mediators in glomerulonephritis. Nephron. 1988;49(4):265–276. [PubMed] [Google Scholar]
  • Izaki S, Okamoto M, Hsu PS, Epstein WL, Fukuyama K. Characterization of elastase associated with granulomatous tissue remodeling. J Cell Biochem. 1986;32(1):79–89. [PubMed] [Google Scholar]
  • Katz P, Fauci AS, Yeager H, Jr, Reen BM. Serum angiotensin-converting enzyme and lysozyme in granulomatous diseases of unknown cause. Ann Intern Med. 1981 Mar;94(3):359–360. [PubMed] [Google Scholar]
  • Braun MG, Csernok E, Gross WL, Müller-Hermelink HK. Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues. Am J Pathol. 1991 Oct;139(4):831–838.[PMC free article] [PubMed] [Google Scholar]
  • Johnson RJ, Couser WG, Alpers CE, Vissers M, Schulze M, Klebanoff SJ. The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med. 1988 Sep 1;168(3):1169–1174.[PMC free article] [PubMed] [Google Scholar]
  • Inamo Y, Harada K, Okuni M, Kimoto K, Takeuchi S, Sakurabayashi I. Immunoreactive polymorphonuclear leukocyte elastase in complex with alpha 1-antitrypsin in Kawasaki disease. Acta Paediatr Jpn. 1987 Apr;29(2):202–205. [PubMed] [Google Scholar]
  • Hällgren R, Gudbjörnsson B, Larsson E, Fredens K. Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis. Ann Rheum Dis. 1991 Dec;50(12):946–949.[PMC free article] [PubMed] [Google Scholar]
  • Fortin PR, Fraser RS, Watts CS, Esdaile JM. Alpha-1 antitrypsin deficiency and systemic necrotizing vasculitis. J Rheumatol. 1991 Oct;18(10):1613–1616. [PubMed] [Google Scholar]
  • Deguchi Y, Shibata N, Kishimoto S. Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin Exp Immunol. 1990 Aug;81(2):311–314.[PMC free article] [PubMed] [Google Scholar]
  • Mathieson PW, Lockwood CM, Oliveira DB. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Immunol Immunopathol. 1992 May;63(2):135–141. [PubMed] [Google Scholar]
  • Schmitt WH, Csernok E, Gross WL. ANCA and infection. Lancet. 1991 Jun 8;337(8754):1416–1417. [PubMed] [Google Scholar]
  • Esaguy N, Aguas AP, van Embden JD, Silva MT. Mycobacteria and human autoimmune disease: direct evidence of cross-reactivity between human lactoferrin and the 65-kilodalton protein of tubercle and leprosy bacilli. Infect Immun. 1991 Mar;59(3):1117–1125.[PMC free article] [PubMed] [Google Scholar]
  • Couldery AD. Tuberculosis of the upper respiratory tract misdiagnosed as Wegener's granulomatosis--an important distinction. J Laryngol Otol. 1990 Mar;104(3):255–258. [PubMed] [Google Scholar]
  • Lai KN, Jayne DR, Brownlee A, Lockwood CM. The specificity of anti-neutrophil cytoplasm autoantibodies in systemic vasculitides. Clin Exp Immunol. 1990 Nov;82(2):233–237.[PMC free article] [PubMed] [Google Scholar]
  • Jennette JC, Falk RJ. Diagnostic classification of antineutrophil cytoplasmic autoantibody-associated vasculitides. Am J Kidney Dis. 1991 Aug;18(2):184–187. [PubMed] [Google Scholar]
  • Mårtensson U, Nåssberger L. Circulating autoantibodies directed against beta-glucuronidase. Autoimmunity. 1992;11(3):213–214. [PubMed] [Google Scholar]
  • Cilursu AM, Goeken J, Olson RR. Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome. Ann Rheum Dis. 1991 Nov;50(11):817–819.[PMC free article] [PubMed] [Google Scholar]
  • Jaunkalns R, Shear NH, Sokoluk B, Gardner D, Claas F, Uetrecht JP. Antimyeloperoxidase antibodies and adverse reactions to clozapine. Lancet. 1992 Jun 27;339(8809):1611–1612. [PubMed] [Google Scholar]
  • Kaufman LD, Finn AF, Jr, Seidman RJ, Pampati J, Peress NS, Miller F, Sokoloff L, Gruber BL. Eosinophilic neuritis, perimyositis, and vasculitis associated with ingestion of L-tryptophan. J Rheumatol. 1990 Jun;17(6):795–800. [PubMed] [Google Scholar]
  • Snider GL. The do-not-resuscitate order. Ethical and legal imperative or medical decision? Am Rev Respir Dis. 1991 Mar;143(3):665–674. [PubMed] [Google Scholar]
  • Jayne DR, Marshall PD, Jones SJ, Lockwood CM. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990 Mar;37(3):965–970. [PubMed] [Google Scholar]
  • Weber MF, Andrassy K, Pullig O, Koderisch J, Netzer K. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol. 1992 Jan;2(7):1227–1234. [PubMed] [Google Scholar]
  • Wu MJ, Rajaram R, Shelp WD, Beirne GJ, Burkholder PM. Vasculitis in Goodpasture's syndrome. Arch Pathol Lab Med. 1980 Jun;104(6):300–302. [PubMed] [Google Scholar]
  • Gallicchio MC, Savige JA. Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections. Clin Exp Immunol. 1991 May;84(2):232–237.[PMC free article] [PubMed] [Google Scholar]
  • Modesto A, Keriven O, Dupré-Goudable C, Durand D, Suc JM. There is no renal difference between Wegener's granulomatosis and micropolyarteritis. Contrib Nephrol. 1991;94:191–194. [PubMed] [Google Scholar]
  • Juby A, Johnston C, Davis P, Russell AS. Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol. 1992 Mar;31(3):185–188. [PubMed] [Google Scholar]
  • Murty GE, Mains BT, Middleton D, Maxwell AP, Savage DA. HLA antigen frequencies and Wegener's granulomatosis. Clin Otolaryngol Allied Sci. 1991 Oct;16(5):448–451. [PubMed] [Google Scholar]
  • Hay EM, Beaman M, Ralston AJ, Ackrill P, Bernstein RM, Holt PJ. Wegener's granulomatosis occurring in siblings. Br J Rheumatol. 1991 Apr;30(2):144–145. [PubMed] [Google Scholar]
  • Antonovych TT, Sabnis SG, Tuur SM, Sesterhenn IA, Balow JE. Morphologic differences between polyarteritis and Wegener's granulomatosis using light, electron and immunohistochemical techniques. Mod Pathol. 1989 Jul;2(4):349–359. [PubMed] [Google Scholar]
  • Gross WL. Wegener's granulomatosis. New aspects of the disease course, immunodiagnostic procedures, and stage-adapted treatment. Sarcoidosis. 1989 Mar;6(1):15–29. [PubMed] [Google Scholar]
  • Csernok E, Lüdemann J, Gross WL, Bainton DF. Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am J Pathol. 1990 Nov;137(5):1113–1120.[PMC free article] [PubMed] [Google Scholar]
  • Müller GA, Markovic-Lipkovski J, Müller CA. Intercellular adhesion molecule-1 expression in human kidneys with glomerulonephritis. Clin Nephrol. 1991 Oct;36(4):203–208. [PubMed] [Google Scholar]
  • Hauschild S, Schmitt WH, Kekow J, Szymkowiak C, Gross WL. Hohe Serumspiegel von ICAM-1 bei der aktiven generalisierten Wegenerschen Granulomatose. Immun Infekt. 1992 Jul;20(3):84–85. [PubMed] [Google Scholar]
  • Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4115–4119.[PMC free article] [PubMed] [Google Scholar]
  • Lai KN, Lockwood CM. The effect of anti-neutrophil cytoplasm autoantibodies on the signal transduction in human neutrophils. Clin Exp Immunol. 1991 Sep;85(3):396–401.[PMC free article] [PubMed] [Google Scholar]
  • Donald KJ, Edwards RL, McEvoy JD. An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis. Pathology. 1976 Apr;8(2):161–169. [PubMed] [Google Scholar]
  • Brasile L, Kremer JM, Clarke JL, Cerilli J. Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis. Am J Med. 1989 Jul;87(1):74–80. [PubMed] [Google Scholar]
  • Frampton G, Jayne DR, Perry GJ, Lockwood CM, Cameron JS. Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol. 1990 Nov;82(2):227–232.[PMC free article] [PubMed] [Google Scholar]
  • Ferraro G, Meroni PL, Tincani A, Sinico A, Barcellini W, Radice A, Gregorini G, Froldi M, Borghi MO, Balestrieri G. Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol. 1990 Jan;79(1):47–53.[PMC free article] [PubMed] [Google Scholar]
  • Savage CO, Pottinger BE, Gaskin G, Lockwood CM, Pusey CD, Pearson JD. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol. 1991 Jul;85(1):14–19.[PMC free article] [PubMed] [Google Scholar]
  • Targan SR, Landers CJ, King NW, Podolsky DJ, Shanahan F. Ulcerative colitis-linked antineutrophil cytoplasmic antibody in the cotton-top tamarin model of colitis. Gastroenterology. 1992 May;102(5):1493–1498. [PubMed] [Google Scholar]
Department of Clinical Rheumatology, Medical University of Lübeck, Bad Bramstedt, Germany.
Department of Clinical Rheumatology, Medical University of Lübeck, Bad Bramstedt, Germany.
Copyright notice
Abstract
The past decade has seen an explosion of data on the new group of autoantibodies known collectively as ANCA (anti-neutrophil cytoplasmic antibodies). ANCA are specific for granule proteins of granulocytes and monocytes and induce distinct fluorescence patterns, e.g. the cytoplasmic (classic) cANCA and the perinuclear pANCA. cANCA is induced by antibodies directed against Proteinase 3 (PR3; PR3-ANCA) in about 90% of all ANCA-positive sera, and pANCA is induced by antibodies against myeloperoxidase (MPO; MPO-ANCA) in about 40%. A further staining pattern, which does not have a clear cut association with a distinct granule protein, is sometimes seen in chronic inflammatory bowel diseases. PR3-ANCA are serological markers for Wegener's granulomatosis (WG) and MPO-ANCA are associated with certain subtypes of primary vasculitides. Evidence exists that both the autoantigen and ANCA participate in the pathogenesis of at least the group of 'ANCA-associated vasculitides'.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.